Cargando…

CD4(+) T‐cell subsets and host defense in the lung

CD4(+) T‐helper subsets are lineages of T cells that have effector function in the lung and control critical aspects of lung immunity. Depletion of these cells experimentally or by drugs or human immunodeficiency virus (HIV) infection in humans leads to the development of opportunistic infections as...

Descripción completa

Detalles Bibliográficos
Autor principal: Kolls, Jay K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3576701/
https://www.ncbi.nlm.nih.gov/pubmed/23405903
http://dx.doi.org/10.1111/imr.12030
_version_ 1782259874861678592
author Kolls, Jay K.
author_facet Kolls, Jay K.
author_sort Kolls, Jay K.
collection PubMed
description CD4(+) T‐helper subsets are lineages of T cells that have effector function in the lung and control critical aspects of lung immunity. Depletion of these cells experimentally or by drugs or human immunodeficiency virus (HIV) infection in humans leads to the development of opportunistic infections as well as increased rates of bacteremia with certain bacterial pneumonias. Recently, it has been proposed that CD4(+) T‐cell subsets may also be excellent targets for mucosal vaccination to prevent pulmonary infections in susceptible hosts. Here, we review recent findings that increase our understanding of T‐cell subsets and their effector cytokines in the context of pulmonary infection.
format Online
Article
Text
id pubmed-3576701
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-35767012014-03-01 CD4(+) T‐cell subsets and host defense in the lung Kolls, Jay K. Immunol Rev Invited Reviews CD4(+) T‐helper subsets are lineages of T cells that have effector function in the lung and control critical aspects of lung immunity. Depletion of these cells experimentally or by drugs or human immunodeficiency virus (HIV) infection in humans leads to the development of opportunistic infections as well as increased rates of bacteremia with certain bacterial pneumonias. Recently, it has been proposed that CD4(+) T‐cell subsets may also be excellent targets for mucosal vaccination to prevent pulmonary infections in susceptible hosts. Here, we review recent findings that increase our understanding of T‐cell subsets and their effector cytokines in the context of pulmonary infection. John Wiley and Sons Inc. 2013-03 2013-02-13 /pmc/articles/PMC3576701/ /pubmed/23405903 http://dx.doi.org/10.1111/imr.12030 Text en © 2013 John Wiley & Sons A/S. Published by Blackwell Publishing Ltd This article is being made freely available through PubMed Central as part of the COVID-19 public health emergency response. It can be used for unrestricted research re-use and analysis in any form or by any means with acknowledgement of the original source, for the duration of the public health emergency.
spellingShingle Invited Reviews
Kolls, Jay K.
CD4(+) T‐cell subsets and host defense in the lung
title CD4(+) T‐cell subsets and host defense in the lung
title_full CD4(+) T‐cell subsets and host defense in the lung
title_fullStr CD4(+) T‐cell subsets and host defense in the lung
title_full_unstemmed CD4(+) T‐cell subsets and host defense in the lung
title_short CD4(+) T‐cell subsets and host defense in the lung
title_sort cd4(+) t‐cell subsets and host defense in the lung
topic Invited Reviews
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3576701/
https://www.ncbi.nlm.nih.gov/pubmed/23405903
http://dx.doi.org/10.1111/imr.12030
work_keys_str_mv AT kollsjayk cd4tcellsubsetsandhostdefenseinthelung